Jackie Fortier
speaker
36 appearances
5 recordings
1 series
first heard Apr 2026
last heard 10 May
Jackie Fortier’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 5 in all, peaking in May 2026 with 3.
Appearances
Starting July 1st, GLP-1 medications like Wegovy and Zepbound will be available to some Medicare enrollees for weight loss for the first time.
The program will cap the monthly cost of the popular drugs at $50.
Without insurance, these drugs currently cost hundreds of dollars.
To qualify, people need a doctor's note and Medicare Part D.
They also need to be clinically overweight, plus have a condition like heart disease or prediabetes.
But there are catches.
The $50 copay won't count toward the annual out-of-pocket limit.
The pilot also expires in December 2027, with no guarantee that the drugs will be covered under traditional Medicare after it ends.
Starting July 1st, GLP-1 medications like Wegovi and Zepbound will be available to some Medicare enrollees for weight loss for the first time.
The program will cap the monthly cost of the popular drugs at $50.
Without insurance, these drugs currently cost hundreds of dollars.
To qualify, people need a doctor's note and Medicare Part D. They also need to be clinically overweight, plus have a condition like heart disease or prediabetes.
But there are catches.
The $50 copay won't count toward the annual out-of-pocket limit.
The pilot also expires in December 2027, with no guarantee that the drugs will be covered under traditional Medicare after it ends.
That's Jackie Fortier reporting.
This is NPR News.
Starting July 1st, GLP-1 medications like Wegovi and Zepbound will be available to some Medicare enrollees for weight loss for the first time.
To qualify, people need a doctor's note and Medicare Part D. They also need to be clinically overweight, plus have a condition like heart disease or prediabetes.
But there are catches.
Showing 1–20 of 36 · page 1 of 2
Next →